APA (7th ed.) Citation

Kwarteng, A., Asiedu, E., Sylverken, A., Larbi, A., Mubarik, Y., & Apprey, C. (2021). In silico drug repurposing for filarial infection predicts nilotinib and paritaprevir as potential inhibitors of the Wolbachia 5′-aminolevulinic acid synthase. Nature Portfolio.

Chicago Style (17th ed.) Citation

Kwarteng, Alexander, Ebenezer Asiedu, Augustina Sylverken, Amma Larbi, Yusif Mubarik, and Charles Apprey. In Silico Drug Repurposing for Filarial Infection Predicts Nilotinib and Paritaprevir as Potential Inhibitors of the Wolbachia 5′-aminolevulinic Acid Synthase. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Kwarteng, Alexander, et al. In Silico Drug Repurposing for Filarial Infection Predicts Nilotinib and Paritaprevir as Potential Inhibitors of the Wolbachia 5′-aminolevulinic Acid Synthase. Nature Portfolio, 2021.